Tuesday, 30 June 2026
College of Psychiatrists Lunchtime Series (COPLUS)
12:30 - 1:30 pm
Treatment-resistant depression remains a major public health challenge. This randomized, double-blind Phase 3 clinical trial aims to evaluate whether individualised connectome-guided localization improves the antidepressant efficacy of accelerated intermitten theta burst stimulation (iTBS) in an Asian population. By directly comparing individualised connectome-guided versus anatomically guided accelerated iTBS, this study will provide the first Asian-based validation of precision-guided neromodulation for depression and inform future clinical practice and policy in personalized psychiatry.
Join us in this lunchtime presentation and discussion of the preliminary results.
Thursday, 14 May 2026
7:30 - 9:30 pm
Sheraton Towers Singapore | Topaz & Opal Rooms
Navigating Psychiatric Practice in the Age of AI
This talk explores how psychiatric practice can navigate crosscurrents-- balancing innovation with ethics and technology with the enduring human essence of care.
Thursday, 23 April 2026
College of Psychiatrists Lunchtime Series (COPLUS)
12:30 - 1:30 pm
via Zoom
The past decade has seen a revolutionary transformation in dementia care, shifting the paradigm from nihilism to hope. This session provides a concise overview of the key breakthroughs reshaping the approach to Alzheimer's disease.
The talk will cover key advances in treatment and support, including the efficacy and safety of new anti-amyloid agents, targetted therapies for agitation, evidence-based risk reduction, and a psychologically-informed approach to the caregiver journey. Attendees will gain a clear framework for navigating the rapidly evolving landscape of dementia care in the Singapore context.
